International Clinical Trial: Efficacy of Compound Qingdai Capsules in the Treatment of Moderate-to-Severe Psoriasis and Its Effects on Immune-Inflammatory and Angiogenic Markers: A Randomized Controlled Clinical Study

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121671) titled 'Efficacy of Compound Qingdai Capsules in the Treatment of Moderate-to-Severe Psoriasis and Its Effects on Immune-Inflammatory and Angiogenic Markers: A Randomized Controlled Clinical Study' on April 1.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Gong An County People's Hospital

Condition: Psoriasis

Intervention: Compound Qingdai Capsule intervention group:Compound Qingdai Capsules, 4 capsules each time, 3 times a day.

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-01

Target Sample Size: Compound Qingdai Capsule intervention group:35;Blank c...